The field of thrombosis has taken a major leap forward with publication of the largest ever stroke prevention trial (edoxaban versus warfarin) in patients with atrial fibrillation (New England Journal of Medicine November 2013). In addition, the Lancet has just published (December 5) a scientific overview of more than 70,000 atrial fibrillation patients randomized in clinical trials of novel oral anticoagulants versus warfarin to prevent stroke. Christian T. Ruff, MD is a Principal Investigator of both of these reports.
I am pleased to announce that Dr. Ruff was just elected to become the 7th Member of the NATF Board of Directors.
Read the full President's Letter here.
Ron Feinstein, Chair of the 2013 Annual Fund, hosted a kick-off reception at Pine Brook Country Club on October 10. Click here to learn more about the Annual Fund and how your support makes a difference.
NATF members have access to the most up-to-date program materials, including video lectures and slide presentations from the 2013 Thrombosis Summit Weekend. Click here to learn more about becoming a member.
Our 18-month snapshot of NATF’s activities shows how your support reinforces and catalyzes our ability to deliver superior educational resources for patients and healthcare professionals alike in the fight against thrombosis.
View the full report here.
A Message from Ron Feinstein
Chair of the 2013 Annual Fund
When I was asked to chair the 2013 Annual Fund campaign, it was an easy “yes”. Every once in a great while, we have an opportunity to do something that will make a difference in people’s lives. Doing something good is special and derives tremendous personal satisfaction. Doing something that will save people’s lives is very special, and most people—other than clinicians—never have that opportunity.
We have the opportunity to save lives by fighting thrombosis and related cardiovascular diseases such as pulmonary embolism, DVT, stroke in atrial fibrillation, and myocardial infarction. We can do this by supporting NATF with a contribution to the Annual Fund.
Read more about NATF's 2013 Annual Fund here.
Join NATF for a complimentary CME educational activity for healthcare professionals in the New England and Northeast region.
Evolving Risk Stratification and Treatment Paradigms for Stroke Prevention in Atrial Fibrillation
Saturday, December 7, 2013
Breakfast: 7:30 AM
Scientific Symposium: 8:30 – 11:30 AM
Boston Marriott Long Wharf, 296 State Street, Boston, MA
This symposium is designed to decipher the maze of risk-specific interventions for AF, with a special focus on risk assessment and thromboprophylaxis for special populations, including those who are at high risk, and those who are unsuitable or intolerant of warfarin. Click here for more information and to register.
Anticoagulation Seminar Available Online!
On November 2 Brigham and Women’s Hospital Anticoagulation Management Service hosted its third annual Patient Seminar. The entire program is available to watch online – just click the link below!
You’ll learn comparisons between warfarin and novel oral anticoagulants, guidelines for managing warfarin around surgery and procedures, dietary and lifestyle recommendations, and information on self-testing and self-management.
Despite the availability of new oral anticoagulants, which do not require monitoring or dosage adjustments, many patients choose to remain on warfarin. “Physicians and patients are being very thoughtful about the transition from warfarin to these new agents,” says Julie Atay, PharmD, MBA, Anticoagulation Services Manager at BWH. She adds, “The market entry of novel oral anticoagulants has brought greater attention to the need to anticoagulate our patients, especially those with atrial fibrillation.”
Click here to see the BWH AMS Patient Seminar!
NATF video webcasts are now live on Pri-Med.com
These accredited educational videos, filmed at the 2013 NATF Thrombosis Summit, will provide you with a comprehensive, multidisciplinary overview of major issues concerning acute coronary syndromes (ACS), stroke prevention in atrial fibrillation (AF), and venous thromboembolism (VTE).
View the videos by topic here.
NeNe Leakes 'Thankful to be Alive' After Blood Clots Found on Lung
People: 19 November 2013 - NeNe Leakes says she's lucky to be alive after doctors found blood clots on her lung.
The Real Housewives of Atlanta star wrote a post on her website Tuesday explaining that she'd gone to the hospital after feeling "a little short of breath."
Read the full article here.
ENGAGE AF-TIMI 48: Once-Daily Edoxaban Noninferior to Warfarin in AF for Stroke Prevention, Cuts Bleeding Risks
Medscape: 19 November 2013 - Once-daily therapy with the oral factor Xa inhibitor edoxaban (Lixiana, Daiichi-Sankyo) at either of two dosages was noninferior to warfarin for preventing stroke or systemic embolism in a randomized atrial-fibrillation (AF) trial—a behemoth at >20 000 patients.
Read the full article here.
American Heart Association council honors Harvard investigator for discovery of new life-saving heart attack treatment
Heart.org: 18 November 2013 - The American Heart Association’s Council on Clinical Cardiology presented its James B. Herrick Award for outstanding achievement in clinical cardiology to Marc Alan Pfeffer, M.D., Ph.D., of Harvard Medical School “for acclaimed research showing how cardiac muscle damage occurs during a heart attack, a discovery that led to new life-saving treatment.”
View the full article here.